Receives U.S. EXIM Bank Board Approval for a $11M Loan to Produce "All-American" Titanium Products
Summary
IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce that the Board of Directors of the Export-Import Bank of the United States (EXIM Bank) has approved an equipment finance loan of US$11.0 million (EXIM Loan). These manufacturing assets will enhance the IperionXs capabilities to produce a broad array of high-performance titanium components, leveraging proprietary and patented technologies at its Advanced Manufacturing Center in Virginia.This financing initiative is directly aligned with EXIM Banks strategic objectives, notably the Make More in America Initiative and the China and Transformational Exports Program, which aim to strengthen U.S. manufacturing capabilities, mitigate foreign supply chain vulnerabilities, and bolster economic resilience and national security.The EXIM Loan provides IperionX with a low-cost, non-dilutive funding pathway to further scale its advanced materials and additive manufacturing capabilities, and underpin a fully integrated, end-to-end titanium supply chain within the United States. Titanium is prized for its superior strength-to-weight ratio, exceptional corrosion resistance, and outstanding performance under extreme conditions, making it critical for advanced industries such as aerospace, defense, automotive, and healthcare. Currently, the U.S. is overwhelmingly reliant on foreign sources for primary titanium (sponge) and titanium minerals, creating significant economic and national security vulnerabilities.Through its Advanced Manufacturing Center, IperionX is utilizing its patented technologies to produce high-value titanium products in Virginia, creating highly-skilled American manufacturing jobs and addressing critical supply chain gaps. The EXIM Loan directly supports IperionXs mission to re-shore a low-cost, uninterruptable All-American titanium supply chain, essential for both national security and sustained economic growth.The proposed EXIM Loan remains subject to the agreement and execution of binding documentation.